Outside the Lab COVID-19, Point of care testing, Microbiology and immunology, Technology and innovation

Yes, We Gly-Can!

Glycan recognition assays could improve COVID-19 diagnosis

Michael Schubert | 04/01/2020 | Quick Read

Credit: Iceni Diagnostics Ltd., Norwich, UK.

A new test seeks to identify viruses, including influenza and SARS-CoV-2, by glycan recognition. Many viruses invade humans via the respiratory tract, whose cells are coated in glycans that the viruses recognize as part of their infectious process. By reversing this process using an artificial glycan receptor, diagnostic devices can capture the virus, yielding a yes/no answer in under 20 minutes. But speed is not the only advantage over PCR-based diagnostic methods; the device is also hand-held, meaning it can be used at the point of care, and glycan-based testing is unaffected by changes to the virus’ genetic code.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Outside the Lab COVID-19, Point of care testing, Microbiology and immunology, Technology and innovation

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

NEXTFLEX Variant-Seq™ SARS-CoV-2 Kit

07/12/2021 | Contributed by PerkinElmer

Fully automated quantification of Meropenem, Tazobactam, Piperacillin and Dexamethasone in plasma

05/04/2021 | Contributed by Shimadzu

Outside the Lab Pathologists’ assistants

Pathologists’ Assistants: Bridging the Gap

09/26/2020

Outside the Lab Point of care testing

A Question of Quality

11/25/2019 | Sponsored by Royal College of Pathologists

Outside the Lab Screening and monitoring

Determining tumour mutation burden using Oncomine Tumour Mutation Load Assay

04/18/2018 | Sponsored by Thermo Fisher Scientific

Subspecialties Microbiology and immunology

Pathology’s Role in Fighting Antimicrobial Resistance

08/08/2022 | Liv Gaskill

Diagnostics Liquid biopsy

Liquid Biopsies: Reach for the Stars

08/11/2022 | Dan Norton | 3 min read

Diagnostics Biochemistry and molecular biology

Future Trends in Spatial Biology

08/10/2022 | Tian Yu | 8 min read

Outside the Lab Profession

Pathology in Challenging Times

08/03/2022 | Gilbert Nkya | 3 min read

Diagnostics COVID-19

Solving the Challenge of COVID-19

08/01/2022 | Wei Juan Wong | 3 min read